Jason Wild, a Director and 10% Holder, acquired 52,100 Common Shares on a direct ownership basis at a price of $3.410 on November 26th, 2019. This represents a $177,661 investment into the company's shares and an account share holdings change of 26.3%.
TerrAscend is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
TerrAscend Corp is a Canada-based company engaged in providing products, brands, and services to the cannabinoid market. The Company, through its subsidiary TerrAscend Canada Inc., is a producer of medical and adult use cannabis. It also operates through various businesses, including The Apothecarium, a cannabis dispensary with retail locations in California and Nevada; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ascendant Laboratories Inc., a biotechnology and licensing company focused on cannabinoid expressing plants; Solace RX Inc., a Drug Preparation Premises (DPP) focused on the development of formulations and delivery forms; and Valhalla Confections, a manufacturer of premium cannabis-infused edibles. TerrAscend Corp. (TER) has below median officer and director direct ownership compared to its small-cap peers in the market, based on our estimate using SEDI data. According to regulatory filings yesterday, one insider has invested a total amount of $177,661.
No Comments